233 related articles for article (PubMed ID: 9435250)
21. Optimized selection of anti-tumor recombinant antibodies from phage libraries on intact cells.
Pavoni E; Vaccaro P; Anastasi AM; Minenkova O
Mol Immunol; 2014 Feb; 57(2):317-22. PubMed ID: 24240062
[TBL] [Abstract][Full Text] [Related]
22. Releasable PEGylation of mesothelin targeted immunotoxin SS1P achieves single dosage complete regression of a human carcinoma in mice.
Filpula D; Yang K; Basu A; Hassan R; Xiang L; Zhang Z; Wang M; Wang QC; Ho M; Beers R; Zhao H; Peng P; Zhou J; Li X; Petti G; Janjua A; Liu J; Wu D; Yu D; Zhang Z; Longley C; FitzGerald D; Kreitman RJ; Pastan I
Bioconjug Chem; 2007; 18(3):773-84. PubMed ID: 17346030
[TBL] [Abstract][Full Text] [Related]
23. An anti-CD30 single-chain Fv selected by phage display and fused to Pseudomonas exotoxin A (Ki-4(scFv)-ETA') is a potent immunotoxin against a Hodgkin-derived cell line.
Klimka A; Barth S; Matthey B; Roovers RC; Lemke H; Hansen H; Arends JW; Diehl V; Hoogenboom HR; Engert A
Br J Cancer; 1999 Jun; 80(8):1214-22. PubMed ID: 10376974
[TBL] [Abstract][Full Text] [Related]
24. Specific killing of HIV-infected lymphocytes by a recombinant immunotoxin directed against the HIV-1 envelope glycoprotein.
Bera TK; Kennedy PE; Berger EA; Barbas CF; Pastan I
Mol Med; 1998 Jun; 4(6):384-91. PubMed ID: 10780881
[TBL] [Abstract][Full Text] [Related]
25. Enhancement of scFv fragment reactivity with target antigens in binding assays following mixing with anti-tag monoclonal antibodies.
Wang X; Campoli M; Ko E; Luo W; Ferrone S
J Immunol Methods; 2004 Nov; 294(1-2):23-35. PubMed ID: 15604013
[TBL] [Abstract][Full Text] [Related]
26. Improved stability and yield of a Fv-toxin fusion protein by computer design and protein engineering of the Fv.
Chowdhury PS; Vasmatzis G; Beers R; Lee B; Pastan I
J Mol Biol; 1998 Sep; 281(5):917-28. PubMed ID: 9719644
[TBL] [Abstract][Full Text] [Related]
27. Selection of tumor-specific internalizing human antibodies from phage libraries.
Poul MA; Becerril B; Nielsen UB; Morisson P; Marks JD
J Mol Biol; 2000 Sep; 301(5):1149-61. PubMed ID: 10966812
[TBL] [Abstract][Full Text] [Related]
28. Antitumor activity and pharmacokinetics in mice of a recombinant immunotoxin containing a disulfide-stabilized Fv fragment.
Reiter Y; Pai LH; Brinkmann U; Wang QC; Pastan I
Cancer Res; 1994 May; 54(10):2714-8. PubMed ID: 8168102
[TBL] [Abstract][Full Text] [Related]
29. [Construction of phage display antibody library to MCF-7 cells and screening of single-chain antibodies against breast cancer cells].
Zhao Y; Wang QM; Fu XQ; Chen JZ; Fan GC; Chen HP
Sheng Wu Gong Cheng Xue Bao; 2004 Sep; 20(5):667-72. PubMed ID: 15973987
[TBL] [Abstract][Full Text] [Related]
30. Diminution of antibodies directed against tumor cell surface epitopes: a single chain Fv fusion molecule specifically recognizes the extracellular domain of the c-erbB-2 receptor.
Wels W; Harwerth IM; Hynes NE; Groner B
J Steroid Biochem Mol Biol; 1992 Sep; 43(1-3):1-7. PubMed ID: 1381944
[TBL] [Abstract][Full Text] [Related]
31. Novel single-chain variant of antibody against mesothelin established by phage library.
Yakushiji H; Kobayashi K; Takenaka F; Kishi Y; Shinohara M; Akehi M; Sasaki T; Ohno E; Matsuura E
Cancer Sci; 2019 Sep; 110(9):2722-2733. PubMed ID: 31461572
[TBL] [Abstract][Full Text] [Related]
32. Comparison of recombinant immunotoxins against LeY antigen expressing tumor cells: influence of affinity, size, and stability.
Bera TK; Pastan I
Bioconjug Chem; 1998; 9(6):736-43. PubMed ID: 9815167
[TBL] [Abstract][Full Text] [Related]
33. New high affinity monoclonal antibodies recognize non-overlapping epitopes on mesothelin for monitoring and treating mesothelioma.
Zhang YF; Phung Y; Gao W; Kawa S; Hassan R; Pastan I; Ho M
Sci Rep; 2015 May; 5():9928. PubMed ID: 25996440
[TBL] [Abstract][Full Text] [Related]
34. HA22 (R490A) is a recombinant immunotoxin with increased antitumor activity without an increase in animal toxicity.
Bang S; Nagata S; Onda M; Kreitman RJ; Pastan I
Clin Cancer Res; 2005 Feb; 11(4):1545-50. PubMed ID: 15746059
[TBL] [Abstract][Full Text] [Related]
35. Improved cytotoxic activity toward cell lines and fresh leukemia cells of a mutant anti-CD22 immunotoxin obtained by antibody phage display.
Salvatore G; Beers R; Margulies I; Kreitman RJ; Pastan I
Clin Cancer Res; 2002 Apr; 8(4):995-1002. PubMed ID: 11948105
[TBL] [Abstract][Full Text] [Related]
36. Single-chain antibodies in pancreatic cancer.
Colcher D; Pavlinkova G; Beresford G; Booth BJ; Batra SK
Ann N Y Acad Sci; 1999 Jun; 880():263-80. PubMed ID: 10415872
[TBL] [Abstract][Full Text] [Related]
37. Identification of novel human CTL epitopes and their agonist epitopes of mesothelin.
Yokokawa J; Palena C; Arlen P; Hassan R; Ho M; Pastan I; Schlom J; Tsang KY
Clin Cancer Res; 2005 Sep; 11(17):6342-51. PubMed ID: 16144939
[TBL] [Abstract][Full Text] [Related]
38. Generation of a Transgenic BALB/c Mouse Line With Selective Expression of Human Mesothelin in Thyroid Gland: Application in Mesothelin-targeted Immunotherapy.
Bera TK; Liu W; Leshem J; King E; Kozlov S; Pastan I
J Immunother; 2019 May; 42(4):119-125. PubMed ID: 30933045
[TBL] [Abstract][Full Text] [Related]
39. One-step single-chain Fv recombinant antibody-based purification of gp96 for vaccine development.
Arnold-Schild D; Kleist C; Welschof M; Opelz G; Rammensee HG; Schild H; Terness P
Cancer Res; 2000 Aug; 60(15):4175-8. PubMed ID: 10945626
[TBL] [Abstract][Full Text] [Related]
40. [Construction and panning of scFv phage display library against recombinant interleukin 4 receptor].
Yang G; Guo H; Liu X; He G; Tian W; Cai K; Wang P; Wang W
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Jun; 32(6):829-33. PubMed ID: 27371853
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
